{"id":"W3113268117","doi":"10.1016/s2152-2650(20)30930-7","title":"MM-128: Carfilzomib, Dexamethasone, and Daratumumab (KdD) Versus Carfilzomib and Dexamethasone (Kd) in Relapsed or Refractory Multiple Myeloma (RRMM): Subgroup Analysis of the Phase 3 CANDOR Study by Number of Prior Lines of Therapy (pLOTs) and Prior Therapies","year":2020,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Carfilzomib; Daratumumab; Medicine; Dexamethasone; Oncology; Subgroup analysis; Multiple myeloma; Internal medicine; Lenalidomide; Meta-analysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00279534,0.001233579,0.003719448,0.0004888193,0.0002556379,0.001205613,0.001016129,0.001065264,0.003604444],"category_scores_gemma":[0.002162856,0.0004800146,0.005811771,0.0006513374,0.0005492509,0.0009747568,0.0006049135,0.002555729,0.0003719887],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008620096,"about_ca_system_score_gemma":0.001037051,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001857055,"about_ca_topic_score_gemma":0.005838541,"domain_scores_codex":[0.9988334,0.0006030615,0.00009501492,0.0001784077,0.00008711912,0.0002029687],"domain_scores_gemma":[0.9988587,0.0004108301,0.0003081405,0.0001235439,0.00003810014,0.0002607151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9656278,0.0007784833,0.006842175,0.000478531,0.009187813,0.00003756422,0.00003600422,0.0008389011,0.001719805,0.00009420489,0.001256946,0.01310174],"study_design_scores_gemma":[0.766072,0.1130869,0.0815984,0.0002468452,0.02925535,0.0002616192,0.0002294835,0.003296348,0.001950328,0.0009022784,0.002986782,0.000113617],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872865,0.009013072,0.0002132669,0.0005283356,0.0002175246,0.0002378676,0.001613537,0.00004659436,0.0008432512],"genre_scores_gemma":[0.9949174,0.001732098,0.0002976058,0.0003831077,0.0002223415,0.0001988523,0.00145207,0.00001391914,0.0007826368],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003719448,"threshold_uncertainty_score":0.01478332,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07079603572095108,"score_gpt":0.3867732350962609,"score_spread":0.3159771993753098,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}